Infection Control Today® asked Matt Pullen, MD, the questions from our readers about the NY polio patient.
With a new paralytic case of polio in New York State, both infection preventionists and the public have questions about what they should know and what to tell those they serve. To get answers for these questions, Infection Control Today® (ICT®) spoke with Matt Pullen, MD, who is a clinical researcher for the medical school at the University of Minnesota, where he is also an assistant professor of infectious disease and international medicine. He is also employed at the Fairview Hospital System.
Pullen discusses what polio is, whether polio is underdiagnosed, and vaccination details for older adults. “Having 3 doses of vaccine by your second birthday confers about 95% protection,” Pullen explains. “There are catch up schedules for people who are older than 2 years old who haven't received all those doses that doctors can use to help someone quickly get immunity they need for protection. But the main people who should be concerned are the ones who are unvaccinated. Some of that's by choice, in which case, I would urge them to reconsider that choice and get vaccinated. Some of [the unvaccination] is in people who have immune deficiencies, specifically B cell depleting syndromes, that make it difficult to mount any kind of vaccine-related immunity, so they should definitely be protected.”
For adults over 50 years, who were vaccinated as children, if they completed the entire series, they are protected. However, Pullen said, “If an adult is unsure if they've had their full series, or if they had an incomplete primary series, you can, like I said before, there's a catch up schedule to get 3 doses of vaccine, and most guidelines recommend if you're unsure of your schedule, or if you know that you didn't complete it, to go ahead and do a 3 core series. Just to be sure that you have that full complete primary series, [the individual] would get 2 doses about 4 weeks apart, and then your third dose [would be] 6 to 12 months after that second one. So within the course of about a year to a year and a half, you could have a complete vaccine series and full protection.”
Polio is also 1 of 3 disease threats facing the US–polio, COVID-19, and monkeypox.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies